Ovid Therapeutics Inc. (OVID) Return on equity 2020–2025
Ovid Therapeutics Inc. (OVID) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-13.3%FY2025 · since FY2020: -185.7% → -13.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -13.3% | +25.4 pp |
| FY2024 | -38.7% | +20.9 pp |
| FY2023 | -59.6% | -18.6 pp |
| FY2022 | -41.0% | -109.3 pp |
| FY2021 | 68.3% | +254.1 pp |
| FY2020 | -185.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice